[Skip to Content]
[Skip to Content Landing]
Views 476
Citations 0
Correction
November 5, 2019

Incorrect Y-Axis Labels and Minor Data Errors

JAMA. 2019;322(17):1718. doi:10.1001/jama.2019.16264

In the Original Investigation entitled “Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial,”1 published in the July 23/30, 2019, issue of JAMA, the y-axis labels in Figure 3 were incorrectly labeled and there were minor data errors in the Results and Discussion sections. In Figure 3, the y-axis labels were incorrectly labeled and each “Intensive treatment” should be switched to “Standard treatment” and each “Standard treatment” should be switched to “Intensive treatment.” In the first sentence in the Results section of the abstract and in the Results section of the text, “529 [46%] women, 920 [80%] with diabetes” should have been “524 [46%] women, 923 [80%] with diabetes.” Also in the Results section, under “Primary Efficacy Outcome,” the percentage in the first sentence of “3.8% of patients had missing data” should have been “3.6% of patients had missing data.” In the Discussion section, fourth full paragraph, second sentence, “race (29% black), and ethnicity (15% Hispanic)” should have been “race (30% black), and ethnicity (16% Hispanic).” In Supplement 3, Antonios Likourezos’ name was misspelled as “Antonius.” This article was corrected online.

References
1.
Johnston  KC, Bruno  A, Pauls  Q,  et al; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators.  Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial.  JAMA. 2019;322(4):326-335. doi:10.1001/jama.2019.9346PubMedGoogle ScholarCrossref
×